Suppr超能文献

National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learning.

作者信息

Ricciardi Walter, Toumi Mondher

机构信息

European Public Health Association and, Department of Public Health, Catholic University of the Sacred Heart, Rome, Italy.

出版信息

J Mark Access Health Policy. 2015 Sep 14;3. doi: 10.3402/jmahp.v3.29276. eCollection 2015.

Abstract
摘要

相似文献

1
National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learning.
J Mark Access Health Policy. 2015 Sep 14;3. doi: 10.3402/jmahp.v3.29276. eCollection 2015.
2
The National Advisory Group on Immunization (NAGI) of the Republic of South Africa.
Vaccine. 2010 Apr 19;28 Suppl 1:A31-4. doi: 10.1016/j.vaccine.2010.02.029.
5
Strengthening vaccination policies in Latin America: an evidence-based approach.
Vaccine. 2013 Aug 20;31(37):3826-33. doi: 10.1016/j.vaccine.2012.12.062. Epub 2013 Jan 25.
7
Informing decision makers: experience and process of 15 National Immunization Technical Advisory Groups.
Vaccine. 2010 Apr 19;28 Suppl 1:A1-5. doi: 10.1016/j.vaccine.2010.02.025.
8
National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening.
Vaccine. 2010 Apr 19;28 Suppl 1:A18-25. doi: 10.1016/j.vaccine.2010.02.027.
9
Indicators to assess National Immunization Technical Advisory Groups (NITAGs).
Vaccine. 2013 May 28;31(23):2653-7. doi: 10.1016/j.vaccine.2013.01.047. Epub 2013 Feb 8.

引用本文的文献

1
COVID-19 Vaccination Coverage in Italy: How Many Hospitalisations and Related Costs Could Have Been Saved If We Were All Vaccinated?
Front Public Health. 2022 Mar 3;10:825416. doi: 10.3389/fpubh.2022.825416. eCollection 2022.
2
3. How comprehensive can we be in the economic assessment of vaccines?
J Mark Access Health Policy. 2017 Aug 31;5(1):1336044. doi: 10.1080/20016689.2017.1336044. eCollection 2017.
3
2. How is the economic assessment of vaccines performed today?
J Mark Access Health Policy. 2017 Aug 31;5(1):1335163. doi: 10.1080/20016689.2017.1335163. eCollection 2017.
4
Towards a more comprehensive approach for a total economic assessment of vaccines?: 1. The building blocks for a health economic assessment of vaccination.
J Mark Access Health Policy. 2017 Aug 31;5(1):1335162. doi: 10.1080/20016689.2017.1335162. eCollection 2017.

本文引用的文献

1
Comparison of NITAG policies and working processes in selected developed countries.
Vaccine. 2015 Jan 1;33(1):3-11. doi: 10.1016/j.vaccine.2014.09.023. Epub 2014 Sep 23.
2
Valuing vaccination.
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12313-9. doi: 10.1073/pnas.1400475111. Epub 2014 Aug 18.
3
Vaccine-preventable diseases in Europe: where do we stand?
Expert Rev Vaccines. 2014 Aug;13(8):979-87. doi: 10.1586/14760584.2014.933077. Epub 2014 Jun 24.
4
Population access to new vaccines in European countries.
Vaccine. 2013 Jun 12;31(27):2862-7. doi: 10.1016/j.vaccine.2013.04.039. Epub 2013 Apr 28.
5
Adverse drug reactions in older adults: a retrospective study from pharmacovigilance.
Therapie. 2012 Sep-Oct;67(5):471-6. doi: 10.2515/therapie/2012059. Epub 2012 Dec 18.
6
Burden of paediatric influenza in Western Europe: a systematic review.
BMC Public Health. 2012 Nov 12;12:968. doi: 10.1186/1471-2458-12-968.
7
National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening.
Vaccine. 2010 Apr 19;28 Suppl 1:A18-25. doi: 10.1016/j.vaccine.2010.02.027.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验